INTRODUCTION
Regulatory T (Treg) cells, in particular the Foxp3 + CD4 + subset, are critical elements of an organism's defense against pathogens, responsible for reining in an over-exuberant immune response. In lymphoid organs such as the spleen and lymph nodes (LNs), Treg cells usually constitute 10%-20% of the CD4 + T cell compartment. Until recently, our vision of Treg biology was heavily colored by information derived from this circulating pool and its response to an infectious or inflammatory insult. However, it has become increasingly clear that Treg cells can also accumulate in a variety of nonlymphoid tissues, where they exert both anti-inflammatory and homeostatic functions (Panduro et al., 2016) . A paradigmatic ''tissue-Treg'' population is that found in visceral adipose tissue (VAT) of male mice (Feuerer et al., 2009) . VAT-Treg cells, which increase with age to as high as 60%-80% of the local CD4 + T cell compartment, have a transcriptome distinct from those of lymphoid-organ and other nonlymphoid-tissue Treg populations (Feuerer et al., 2009; Cipolletta et al., 2015; Panduro et al., 2016) . This unique phenotype depends critically on the nuclear receptor family member, PPARg (Cipolletta et al., 2012) , the ''master-regulator'' of adipocyte differentiation. VAT-Treg cells display a clonally expanded repertoire of antigen-specific receptors (T cell receptors [TCRs] ) (Feuerer et al., 2009; Kolodin et al., 2015) , suggestive of a response to one or more local antigens (Ags). According to several lines of evidence, these cells regulate local and systemic metabolic indices through a combined effect on both immunocytes and adipocytes (Feuerer et al., 2009; Vasanthakumar et al., 2015) . While these studies (and others) concurred in attributing insulin-sensitizing effects to VAT Tregs in 25-to 35-week-old mice on lean chow, a recent study reported an opposing influence in old mice aged 55-110 weeks (Bapat et al., 2015) . Progress has been made in elucidating the provenance, dependencies, and activities of VAT-Treg cells (Panduro et al., 2016) , but a major stumbling block has been their rarity ($5,000/mouse), exacerbated by an inopportune localization (within fat, classically toxic to T cells during isolation and culture). Hence, certain critical issues have remained unresolved, notably: what molecular and cellular factors drive VAT-Treg accumulation, and when, where, and how is the unique VATTreg phenotype established? To address these questions, we side-stepped the aforementioned experimental difficulties by engineering a transgenic (tg) mouse line carrying the pre-rearranged Tcra and Tcrb genes of an expanded VAT-Treg clone. These mice hosted an exaggerated population of VAT Tregs, the great majority of which expressed the transgene-encoded TCR chains, and had a substantially improved metabolic tenor. This model permitted us to definitively establish a role for TCR specificity, uncover an unexpected function for Foxp3, and evidenced a cell-intrinsic role for the interleukin(IL)-33 receptor in VAT-Treg accumulation in adipose tissue. We also demonstrated that the definitive VAT-Treg phenotype emerged only in cells within adipose tissue, via a two-stage, two-site process. genes are highlighted in red (induced) or blue (repressed). The number of genes from each signature preferentially expressed by one or the other population are shown at the top.
(legend continued on next page) (Kolodin et al., 2015) . Our primary criteria in choosing one of them for the generation of a TCR-tg line were the extent of its expansion and the availability of monoclonal antibodies (mAbs) specific for each of its TCR chains. Clone 53, which constituted 10% of the VAT-Treg population in one of the mice, expressed a TCR comprised of chains carrying the Va2 and Vb4 variable regions, for which mAbs are commercially available. Genomic DNA constructs encoding each of the chains were co-injected into B6 mouse embryos, and a VAT-Treg TCR-tg line (vTreg53) expressing both chains was derived and expanded.
In 20-week-old male Tg + mice, both the frequency and number of total Tregs in VAT, but not in the spleen, were significantly elevated compared with corresponding values for Tg À littermates ( Figure 1A ). Within the TCR-tg mice, there was a strong enrichment for clonotype + Treg, but not Tconv, cells in VAT (vis-à -vis the spleen) ( Figure 1B ). This augmentation was not seen for Tregs in most other nonlymphoid tissues (colon, lung, liver) of Tg + mice; a slight increase in the fraction (although not number) for muscle Tregs most likely reflects fat marbling within that tissue ( Figure S1A ). Of the various adipose depots, epididymal VAT hosted the greatest concentration of total and clonotype + Treg cells, more so than ovarian VAT or peri-renal and subcutaneous adipose tissue (SAT) from either sex (Figure 1C) . Already at 5 weeks, clonotype + Tregs were enriched in VAT of male Tg + mice, a differential that increased with age (Figure S1B, upper) . In contrast, there were minimal age-related changes in the contribution of clonotype + Tconv cells in VAT or spleen (Figure S1B, lower) . VAT Treg cells arise in the thymus during the first weeks of life (Kolodin et al., 2015) ; Va2 + Vb4 + Tregs were most efficiently generated in the thymus of TCR-tg mice during this time-period ( Figure S1C ), after which Tregs with secondary (i.e., non-tg) TCR rearrangements presumably began to emerge. Similar conclusions came from studying vTreg53 TCR-tg mice of Rag À/À genotype in order to avoid secondary rearrangements at the endogenous Tcra and/or Tcrb loci (Figures S1D and S1E). Treg frequencies in VAT and SAT were similar, but the density was much higher in the former case. A major driver of the VAT-Treg phenotype is PPARg (Cipolletta et al., 2012) . Unfortunately, no existing anti-PPARg mAb is suitable for histologic or flow-cytometric analyses. Therefore, we generated a PPARg-reporter mouse line by introducing an IRES-Tdtomato (Tdt) cassette at the beginning of the 3 0 UTR of the Pparg locus. The resulting allele reports expression of both the PPARg1 and PPARg2 isoforms ( Figure S2A ). We crossed Pparg-Tdt and Foxp3-GFP reporter alleles into the vTreg53 TCR-tg line to allow us to follow the emergence and accumulation of true VAT-Treg cells. In clear contrast to the spleen, the vast majority ($80%) of Tregs in VAT from 20-week-old non-tg mice expressed the PPARg reporter ( Figure 1D ). This value rose even higher (to $98%) in clonotype + VAT Tregs from TCR-tg littermates, while it sank (to $35%) in corresponding clonotype À cells. Similar results were obtained using mAbs to quantify expression of three additional proteins reported to preferentially mark VAT Tregs: ST2, KLRG1, and GATA3 (Feuerer et al., 2009; Cipolletta et al., 2012; Vasanthakumar et al., 2015; Kolodin et al., 2015) ( Figure S2B ). Some PPARg + Treg cells were found in muscle and the liver, but levels remained well below those in VAT ( Figure S2C ). For a global perspective, we used RNA sequencing (RNA-seq) to compare the gene-expression profiles of clonotype hi splenic and VAT
Tregs from 20-week-old Tg + Foxp3-GFP reporter mice. The previously defined VAT-Treg up-signature was highly over-represented in TCR-tg VAT Tregs, whereas the down-signature was strongly under-represented ( Figure 1E ). VAT-Treg cells improve insulin sensitivity and other metabolic indicators through effects on local adipocytes and immunocytes, particularly macrophages (MFs) (Feuerer et al., 2009; Vasanthakumar et al., 2015) . Corresponding to elevated frequencies and numbers of VAT Tregs in TCR-tg versus non-tg littermates at 14-16 weeks of age ( Figure S2D ), the frequencies and numbers of VAT CD11c hi
CD11b
hi inflammatory MFs were significantly reduced ( Figures 1F and S2E) , as was expression of most of a panel of inflammatory gene markers ( Figure S2F ). The body and VAT weights of Tg + and Tg À littermates were comparable ( Figure S2G ). Nonetheless, the Tg + mice showed significantly improved insulin sensitivity ( Figure 1G ), glucose tolerance (Figure 1H) , and homeostatic model assessment of insulin resistance (HOMA-IR) values ( Figure S2H ). In brief, we were successful at generating a VAT-Treg TCR-tg mouse line with an enriched Treg population specifically in epididymal adipose tissue, dominated by bona fide VAT Tregs displaying the transgene-encoded Va2 + Vb4 + TCR specificity.
vTreg53 TCR-tg mice showed substantially improved inflammatory and metabolic indices.
Accumulation of VAT-Treg Cells Is Dependent on the TCR Specificity
The specific enrichment of Treg cells in VAT of male vTreg53 TCR-tg mice, including those on a Rag À/À background, argued that the TCR specificity had an important influence on VATTreg accumulation. In support of this notion, a higher fraction of clonotype + than clonotype À Treg cells in the TCR-tg mice were cycling, as estimated from Ki67 staining ( Figure 2A) ; and clonotype + Treg cells had a longer half-life, assessed from bromodeoxyuridine (BrdU) long-term-incorporation followed by chase experiments ( Figure 2B ).
(F) Frequencies (left) and numbers (right) of inflammatory macrophages from 14-to 16-week-old Tg À and Tg + male mice (n R 5). Exemplar dot-plots appear in Figure S2E . (G and H) Metabolic indices for 14-to 16-week-old Tg À and Tg + male mice (n R 5). These findings definitively established that the TCR specificity was a critical driver of Treg accumulation in VAT: Treg cells displaying the vTreg53 specificity were much more ''VATophilic'' than were polyclonal Tregs.
Accumulation of CD4 + T Cells in VAT Depends on Foxp3
Although Foxp3 Figure 2G ), factors that promote specific accumulation of Tregs at that site (Cipolletta et al., 2012; Kolodin et al., 2015) . TCR-tg Tconv cells were also not enriched in VAT 12 weeks after transfer of CD4 + T cells from pooled lymphoid organs of male CD45.2 + Tg + mice into male B6.CD45.1 + recipients ( Figure 2H ). The lack of VAT accumulation was not a matter of timing: the representation of transferred TCR-tg Tconv cells in the spleen peaked a few days after their administration and then crashed, while they occurred at low levels for at least 12 weeks in VAT and SAT ( Figure 2I ). Introduction of Tconv cells sorted from pooled lymphoid organs of TCRtg mice also failed to engender a robust VAT-Tconv population 12 weeks later ( Figure 2J) ; nor did the transferred cells convert to VAT Tregs ( Figure 2K ). Foxp3 is the most important transcription factor (TF) distinguishing Treg and Tconv cells, although it actually accounts for less than half of the classical Treg signature (Hill et al., 2007 Figure 3C ). Interestingly, once the Foxp3-transduced Tconv cells were installed in VAT (6 weeks posttransfer), they had upregulated essentially the entire VAT Treg signature ( Figure 3D ). To address the relevance of differential cycling-gene transcription ( Figure 3C ), we stained T cell populations from 10-week-old TCR-tg mice with the cell-cycle marker, Ki67. Clonotype + Treg cells cycled more actively in VAT than in spleen or SAT ( Figure 3E ). At all three of these sites, clonotype + Tconv cells were in cycle significantly less frequently than were their clonotype + Treg counterparts.
Notably, Foxp3-transduced Tconv cells near-universally expressed PPARg and ST2 within VAT ( Figures 3F and 3G ). Because these two factors promote Treg accumulation specifically in VAT, we asked whether transduction of either one of them alone could replace Foxp3. This proved not to be the case ( Figure 3H ). Thus, quite unexpectedly, Foxp3 is also essential for T cell enrichment in VAT, upstream of PPARg and ST2.
VAT-Treg Cells Rely on Cell-Intrinsic IL-33 Signaling
Two groups have argued that IL-33 has a substantial and direct influence on VAT Treg accumulation (Vasanthakumar et al., 2015; Kolodin et al., 2015) ; however, another group maintained that any influence of IL-33 on VAT Treg cells was primarily indirect, operating via an innate lymphoid cell (ILC)-2 intermediate (Molofsky et al., 2015) . None of these studies examined mice with a Treg-specific ablation of the IL-33 receptor, ST2 (encoded by Il1rl1), and all were confounded by potential replacement of bona fide VAT Treg cells with lymphoid-organ Tregs circulating through and pausing within an empty VAT compartment. Therefore, we generated vTreg53 TCR-tg mice with a homozygous PPARg-Reporter Mice Reveal Two-Step, Two-Site Acquisition of the VAT-Treg Phenotype When, where, and how the definitive phenotype of VAT-Treg cells is acquired are important questions that have been difficult to answer, first, because of the heterogeneity of the Foxp3 + CD4 + population in VAT, hosting both true VAT Tregs and circulating Tregs that display a diversity of TCR specificities Kolodin et al., 2015) , and, second, because there has been no accessible marker for tagging VAT-Treg precursors.
As concerns when, flow-cytometric analysis indicated that cells with a VAT-Treg phenotype were present in Tg + mice from an early age ( Figure 5A ), consistent with our previous, more indirect, arguments (Kolodin et al., 2015) . Certain of the phenotypic markers known to distinguish VAT and spleen Treg cells (e.g., ST2) were expressed in clonotype + VAT Tregs at near-maximum frequencies already at 5 weeks of age (the earliest time-point we could examine), while others (e.g., PPARg, KLRG1) showed a substantial increase with age. In both cases, the fraction of marker-positive VAT-Treg cells was higher in Tg + than Tg À littermates.
As concerns where, we began with a population-level view. RNA-seq analysis was performed on thymic and splenic Treg cells from 2-week-old TCR-tg and non-tg littermates, as well as on splenic and VAT clonotype hi Tregs from 10 week-and 20 week-old Tg + and Tg À littermates. Principal component analysis (PCA) indicated that the definitive VAT-Treg phenotype was not achieved until the cells were installed in the epididymal fat depot, and there was additional evolution of the bulk VAT-Treg transcriptome between 10 and 20 weeks of age for both Tg + and Tg À mice ( Figure 5B ). At these two ages, the VAT-Treg transcriptome appeared to be slightly different in TCR-tg and non-tg littermates. However, it is not possible to say whether the differences seen with advancing age or with transgene positivity reflect changing transcriptional programs or a higher representation of true VAT-Treg cells (as opposed to circulating Tregs). Importantly, at both 10 weeks and 20 weeks of age, the transcriptomes of spleen and VAT-Treg cells appeared to be as different from each other in non-tg mice as they were in TCRtg littermates, the latter presumably enriched in VAT-destined Treg precursors. In addition, for both mature (20-week-old) and young (2-week-old) mice, there was no enrichment of the VAT up-or down-signature in clonotype + splenic Tregs from vTreg53 TCR-tg mice vis-à -vis those of their transgene-negative littermates ( Figure 5C , left and center). This finding held for clonotype + thymic Tregs from 2-week-old TCR-tg mice (a time of active VAT-Treg generation; Figure S1C ) as well (Figure 5C, right) .
For a single-cell view, we exploited the phenotype-tracing potential of PPARg-reporter mice. Unexpectedly, a minor fraction of splenic Foxp3 + CD4 + cells expressed PPARg, although at a lower frequency ( Figure 1D ) and reduced level ( Figure 5D Summary plots show data pooled from two to three independent experiments. Mean ± SD. SVF, stromal vascular fraction. See also Figure S3 . Figure S4B ).
The above findings suggested that part of the VAT-Treg signature, in particular the component induced by cell activation, was already turned on in a subset of the splenic Treg population marked by low levels of PPARg expression, and was further turned up in VAT; whereas most of the component unique to VAT Tregs was not simply activation-associated and was not induced until the cells were installed in VAT. Figure 5F ). This low fraction appeared within the first 2 weeks and was maintained at this low level over the 2-to 8-week period examined ( Figure 5G) Figure 3F ). Overall, the data argued for a two-stage scenario for VAT-Treg diversification. Treg cells displaying a VATophilic TCR were initially induced to express low levels of PPARg and a slice of the VAT-Treg signature within the spleen, but did not take on Compiled data were visualized using t-distributed stochastic neighbor embedding (t-SNE), which permits dimensionality reduction. K-means clustering distinguished seven Treg groupings ( Figure 6A ). Splenic Treg cells were encompassed mainly within three groups (black, red, and green), while VAT Tregs fell mostly within five groups (green, yellow, turquoise, brown, and blue). Importantly, the pattern of Nur77 expression, a well-established correlate of TCR signal-strength (Moran et al., 2011) , was essentially indistinguishable in TCR-tg versus non-tg single Treg cells ( Figure 6B ). Superimposing the VAT-Treg signature onto the t-SNE plot of the compiled data, in heatmap mode, revealed strong induction in the four VAT-dominated clusters, in particular in the turquoise and brown groups; weak induction in VAT:spleen-bridging clusters, mainly in the green group but also in some cells within the blue and black groups; and minimal expression in the bulk of cells in the two spleen-dominated clusters ( Figure 6C , left). To focus on potential splenic precursors of VAT Treg cells, we split out the heatmap data on splenic Tregs ( Figure 6C , center). For both Tg + and Tg À mice, $6% of the cells showed weak, but detectable, expression of the VAT Treg signature, a value quite similar to the <10% splenic PPARg lo Treg cells documented above ( Figure 1D ). Similarly, diagnostic VAT transcripts (e.g., Pparg and IL1rl1) were largely restricted to the four VAT-dominated clusters, although there were a few positive cells in the VAT:spleen-bridging clusters as well ( Figure 6C, right) . Next, we rationalized that a direct comparison of the scRNAseq profiles of Tregs from Tg À and Tg + mice could prove illuminating because, expressing both Foxp3 and an appropriate TCR, essentially all of the latter cells had the potential to become bona fide VAT Tregs. A differential heatmap ( Figure 6D ) revealed striking similarity, with a few notable exceptions: a clear transcript enrichment in the presumably most mature (turquoise and brown) cell clusters in VAT, a less evident enrichment in the bridging region of the splenic black cluster, and an impoverishment in the spleen:VAT-shared (green) cluster in VAT but not spleen. The lack of a more impressive increase in potential splenic precursors fits well with the observation that there seemed to be a cap on the fraction of splenic PPARg lo cells ( Figure 1D ). We then identified a set of mAbs that would permit us to distinguish key VAT Treg subpopulations by flow cytometry. Cells of the turquoise and brown clusters should be ST2 hi CD69 med/hi ( Figure 6E ) and, indeed, this subpopulation was enriched in TCR-tg VAT Tregs displaying high levels of clonotype + TCRs ( Figure 6F ). On the other hand, cells of the green cluster should be ST2 lo CXCR3 hi ( Figure 6E ), and they were largely absent from clonotype + VAT Tregs ( Figure 6G ). Because it has been reported that CXCR3 + Treg cells differentiate in response to interferon (IFN)-g generated during a Th1 response (Koch et al., 2012) , we wondered whether there might be a dearth of Th1 cells in VAT of vTreg53 TCR-tg mice. This proved to be the case (Figure 6H) Figure 7A ). A heatmap plotting the 75 most variable OCRs near signature genes confirmed that the majority of them were acquired specifically in VAT ( Figure 7B ). Some examples of genes exhibiting this pattern were Pparg ( Figure 7C ) and Ctsh ( Figure S5A ), which showed minimal local OCR signals in thymic and splenic Tregs, but strong signals in VAT Tregs. However, it is also worth noting that a substantial fraction of the OCRs near VAT-Treg signature genes were already accessible in the thymus and spleen (TSV-High and TSV-Med) (Figure S5B) . Given the increasing evidence of long-distance chromatin interactions, it is possible that many of these OCRs do not actually control expression of the nearby VAT-Treg signature genes. Alternatively, some of them might be ''primed'' by a common Treg or more general T cell program for a baseline of gene expression, which is then induced upon acquisition of one or more additional key OCRs specifically in VAT. Examples of this pattern were Klrg1, Il1rl1 ( Figure 7C ), and Cxcl2, Pcyt1a ( Figure S5A ), each of which had OCRs unique to VAT as well as common across the tissues examined. Overall, these ATAC-seq data argued for final acquisition of the VAT- Figure 7F) . In brief, then, these genome-wide approaches provided additional support for the notion that diversification of VAT Tregs was not finalized until adipose-tissue residence. See also Figure S5 .
TCR-tg Treg cells recognizing a prostate Ag preferentially accumulate in the prostate gland (Malchow et al., 2013) . The identification of Foxp3 as another driver of VAT-Treg accumulation uncovered an unanticipated function for this primordial Treg TF. Unlike Tregs, Tconv cells from vTreg53 TCRtg mice could not expand and/or be retained in VAT. There were several possible explanations for this difference. First, the exact repertoire of TCRs displayed by Va2 + Vb4 + Treg and Tconv cells might not be identical due to different extents of secondary rearrangement of the endogenous Tcra/b genes. However, even on a Rag1 À/À background, the VAT CD4 + T cell compartment was dominated by Treg cells. Second, Va2 + Vb4
+ Tconv cells might not be able to expand in VAT due to strong suppression by the enriched fat-Treg population in the TCR-tg mice. However, sorted Tconv cells from Tg + mice were still unable to expand in VAT upon transfer into standard B6 recipients. Ectopic expression of Foxp3 was sufficient to drive accumulation of naive TCR-tg Tconv cells in VAT and to promote their acquisition of a bona fide VAT Treg phenotype. Foxp3 and PPARg partake in a common multi-protein complex (Cipolletta et al., 2012) , so it is possible that they act in concert to promote cell enrichment in VAT. Indeed, transduction of PPARg was not able to replace Foxp3 transduction in driving accumulation. The repertoire of chemokine and adhesion receptors induced by Foxp3 expression is another element of potential importance in the differential capacity of Treg and Tconv cells to accumulate in VAT. IL-33 also regulates VAT-Treg enrichment, but whether and to what extent this is a direct effect has been a controversial issue (Vasanthakumar et al., 2015; Kolodin et al., 2015; Molofsky et al., 2015; Panduro et al., 2016) . By abrogating expression of the IL-33 receptor, ST2, specifically in Tregs of vTreg53 TCR-tg mice, we established that ST2 has a substantial cell-intrinsic influence on the accumulation of bona fide VAT Tregs, thus refuting the contention that IL-33 acts on VAT Tregs only via an ILC2 intermediary. Age-dependent enrichment of Treg cells was much reduced in SAT in comparison with VAT (Feuerer et al., 2009) , and our data suggest that differences in IL-33 levels might underlie this difference.
VAT Treg Cells Acquire Their Unique Phenotype in Two Stages at Two Sites At the outset of these studies, two scenarios of VAT-Treg generation seemed most likely: that they were imprinted with a distinct phenotype in the thymus, perhaps reflecting a specific type or site of TCR:MHC-Ag engagement; or their phenotype was not manifest until VAT residence, reflecting microenvironmental adaptation. Our findings revealed that neither of these scenarios was entirely correct.
Unexpectedly, we identified a small population of PPARg lo Treg cells in the spleen. These cells might have been recirculating VAT Tregs, but this seems unlikely because the population's size did not increase with age; in fact, it was present (even somewhat over-represented) in 2-week-old Tg + mice (data not shown). In addition, transfer of splenic PPARg À Tregs into standard B6 mice resulted in the appearance of PPARg + cells first in the spleen and then in VAT. Last, the epigenetic landscape of PPARg lo Treg cells from the spleen was much more like that of their PPARg À splenic counterparts than that of VAT Tregs.
Transcriptomic analysis of PPARg lo splenic Treg cells revealed that they had upregulated a component of the defining VAT-Treg transcriptional program, particularly those transcripts associated with Treg activation. We speculate that this PPARg lo Treg population arose in response to presentation of limiting amounts of cognate self-Ag-possibly together with a particular combination of cytokines-prompting the cells to take on an activated phenotype and exit the secondary lymphoid organs to survey parenchymal tissues. Those Tregs expressing an appropriate TCR, such as vTreg53, would be retained in VAT when they reencounter their Ag (perhaps at higher concentrations) and would then fully acquire the unique VAT phenotype in response to local cues. Interestingly, Tg + mice did not harbor more of the PPARg lo splenic Treg population than did their Tg À littermates, hinting that a limiting niche might control the size of the splenic PPARg lo Treg population, perhaps reflecting the availability of Ag, particular cytokines, and/or PPARg ligands. Overall, these data argue for a scenario that entails layered acquisition of the definitive VAT-Treg gene-expression program, segregated into an activation component induced in secondary lymphoid organs and a tissue-specific component enforced by unique local cues. Interest in boosting or impairing Treg compartments for therapeutic ends continues to grow. In general, the approach has been to modulate Treg cells in a tissue-agnostic manner, not accounting for the different sites that need to be targeted in different disease contexts. Such approaches appear to be less than optimum because they risk provoking generalized immunosuppression or immunostimulation and because they are often poorly adapted for accessing critical Treg cells within the pathologic lesion of interest. Thus, it is imperative to understand how the Treg populations within tissues distinguish themselves so that we can devise effective precision-targeting strategies.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice Male (and, where indicated, female) mice of various ages were produced in our specific pathogen-free facilities at Harvard Medical School, and were fed a chow diet (no. 5058, Lab Diet Picolab Mouse Diet 20) . B6.CD45.2 + , B6.CD45.1 + (i.e., standard B6), and B6.Rag1 À/À mice were purchased from the Jackson Laboratory. Foxp3-GFP (Bettelli et al., 2006) , Foxp3-Cre (Rubtsov et al., 2008) , and Il1rl1 flox (Chen et al., 2015) mice were obtained from Drs V. Kuchroo, A. Rudensky, and R. Lee, respectively, and were backcrossed, then maintained on the B6 background. Mice lacking ST2 specifically on Treg cells were generated by appropriate crossing of the Foxp3-Cre and Il1rl1 flox lines. All experiments were performed using littermate controls.
For generation of the VAT Treg TCR-Tg line (vTreg53), rearranged genomic DNA fragments encoding TRAV14N-3*01 (Va2) TRAJ21*01 (CDR3 sequence: tgtgcagcaagtcctaattacaacgtgctttacttc; Amino acid: CAASPNYNVLYF) and TRBV2*01 (Vb4) TRBJ2-5*01 (CDR3 sequence: tgtgccagcagccaagaagacacccagtacttt; Amino acid: CASSQEDTQYF) were synthesized as gBlocks Gene Fragments (Integrated DNA Technologies), then amplified and cloned, respectively, into the pTacass and pTbcass TCR-tg vectors (Kouskoff et al., 1995) . These Tcra and Tcrb sequences derived from the expanded VAT Treg clone, 53 (Kolodin et al., 2015) . DNA fragments driving expression of TCRa and b were excised, purified, and co-injected into fertilized B6 eggs. Genotyping of the tg mice was performed by polymerase chain reaction (PCR) amplification of rearranged Tcra and Tcrb fragments. The TCR tg mice were further crossed with Foxp3-GFP, Il1rl1 flox Foxp3-Cre, or Rag À/À mice. In all cases, the Tcra plus Tcrb transgene was maintained in the heterozygous state. For generation of the Pparg-Tdt mice, a 4kb homology DNA construct (Pparg5ARM-IRES-Tdt-3ARM) was cloned, comprised of the 5 0 homology arm (1096bp upstream of and including the stop codon of Pparg), the IRES-Tdtomato-Cassette (2006bp), and the 3 0 homology arm (930bp downstream of the stop codon of Pparg). A double-stranded DNA break was introduced close to the start of the 3 0 UTR of the Pparg locus by Cas9 and a single-guide (sg) RNA (protospacer sequence: 5 0 GGAACACGTTGTCAGCGGGT 3 0 ). On the day of injection, the sgRNA (2.5ng/ul), Cas9 mRNA (5 ng/ul, TriLInk Biotechnologies), and linearized double-stranded DNA template (2.5ng/ul) were mixed in 10 mM Tris/0.1 mM EDTA, pH 7.4, and immediately injected into B6 embryos. Resulting founder mice were genotyped by PCR amplification, confirming knocking-in of the IRES-Tdtomato cassette into the start of the 3 0 UTR of the Pparg locus. The Pparg-Tdt mice were further crossed with TCR-tg Foxp3-GFP mice to generate dual-reporter mice.
All experimentation was performed following animal protocols approved by the HMS Institutional Animal Use and Care Committee (protocol IS00001257). + T cells were double-sorted from the spleens of recipient mice one wk after transfer (both controlvector-and Foxp3-transduced groups), or from VAT of recipient mice six wks after transfer (only the Foxp3-transduced group), and were subjected to RNA-seq analysis.
T cell transfers
Long-term BrdU labeling and chase 10wk-old TCR Tg + male mice were given BrdU (Sigma) in the drinking water (0.8mg/ml) and protected from the light for 4 weeks.
BrdU-containing water was changed every 2 days. After 4 weeks of continuous labeling, BrdU was removed from the drinking water and cells from the mice were processed and staining for BrdU at various times following the manufacturer's instructions (APC BrdU Flow Kit, BD Biosciences). Data was expressed as percent of the starting BrdU + Treg pool on day 0 of chase. An exponential decay line was fitted to each dataset to calculate the half-life of cells.
METHOD DETAILS
Cell isolation and flow cytometry Mice were asphyxiated with CO 2 and perfused with 30ml of PBS containing 5mM EDTA. Epididymal VAT, peri-renal VAT, inguinal SAT, liver, hindlimb muscles, lung, and colon from male mice, or ovarian VAT, peri-renal VAT, and inguinal SAT from female mice were excised, minced and digested in a 37 C water bath with shaking as follows: adipose tissues were digested for 20 min with 1.5 mg/ml collagenase type II (Sigma) in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 2% fetal calf serum (FCS); liver was digested in DMEM containing 0.5mg/ml collagenase IV (GIBCO) and 150 ug/ml DNase I (Sigma) for 30 min; skeletal muscle was digested in DMEM containing 2 mg/ml collagenase II (GIBCO) and 150 ug/ml DNase I (Sigma) for 30 min; lung was digested in RPMI containing 4% fetal calf serum (FCS), 10 mM HEPES, 3mg/ml collagenase IV (GIBCO), and 300 ug/mL DNase I (Sigma) for 45 min; the entire colon was incubated in RPMI containing 1mM DTT, 20mM EDTA, and 2% FCS, at 37 C for 15 min to remove epithelial cells. The colon was then minced and dissociated in RPMI containing 1.5mg/ml collagenase II (GIBCO), 0.5mg/ml Dispase (GIBCO), and 1% FCS, at 37 C for 45 min with constant stirring. For all tissues, the digested materials were filtered through a sieve and then a 70um nylon cell strainer. For adipose tissues, the SVF was collected after centrifugation at 450 g for 10 min. For liver and muscle, cells were further enriched for a leukocyte fraction by 40% Percoll (GE Healthcare), underlain with 80% Percoll, and spun for 25 min at 1126 g. For T lymphocyte analysis, cells were stained with anti-CD45.1 (A20), -CD45. KI/KI or wild-type B6 mice were extracted for total RNA and subjected to reverse transcription for cDNA synthesis using the Tdt-RT-REV primer. The isoforms of Pparg were identified by PCR using oligonucleotides specific to either Pparg1 (Pparg1-FWD) or Pparg2 (Pparg2-FWD) in combination with Tdt-RT-REV. Above: scheme of the design. Below: representative agarose gel electrophoresis of the PCR products.
(B) ST2, KLRG1, and GATA3 expression in splenic and VAT Tregs from 20wk-old Tg -and Tg + male mice (n R 5).
(C) PPARg expression in Treg cells from various tissues of 20wk-old Tg -and Tg + male mice (n = 5). N.D., not detectable (due to low cell numbers).
(D) Frequencies (left) and numbers (right) of total VAT Tregs from 14-16wk-old Tg -and Tg + male mice (n R 5).
(E) Representative dot-plots showing the gating strategy for identification of inflammatory MFs from VAT of 14-16wk-old Tg -and Tg + male mice. Numbers indicate fraction of cells within the designated gate. Corresponding summary data appear in Figure 1F .
(F) PCR quantification of inflammatory gene transcripts in VAT from 14-16wk-old Tg -and Tg + male mice (n = 8).
(G) Body (left) and VAT (right) weights of 14-16wk-old Tg -and Tg + male mice (n R 5).
(H) Correlation of homeostatic model assessment of insulin resistance (HOMA-IR) with number of VAT Tregs in 14-16wk-old Tg -and Tg + male mice (n R 5).
Numbers refer to the fraction of cells in the indicated gate. Abbreviations as per Figure 1 . All summary plots show mean ± SD. 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 A) Genome-browser tracks of Tg + Treg ATAC-seq reads at some PPARg-dependent genes, as defined in (Cipolletta et al., 2012) .
(B) Hierarchical clustering of all OCRs ± 100Kb of VAT up-signature genes. Delineation of five clusters, labeled by their accessibility signal in thymic (T), splenic (S), or VAT (V) Tregs. All summary plots show mean ± SD.
